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ABSTRACT
Background: Over 400,000 people live in care home settings in theUK.Oneway of understanding and improving
the quality of care provided is by measuring and understanding the quality of life (QoL) of those living in care
homes. This review aimed to identify and examine the psychometric properties including feasibility of use of
dementia-speciﬁc QoL measures developed or validated for use in care settings.
Design: Systematic review.
Methods: Instruments were identiﬁed using four electronic databases (PubMed, PsycINFO, Web of
Science, and CINAHL) and lateral search techniques. Searches were conducted in January 2017. Studies
which reported on the development and/or validation of dementia speciﬁc QoL instruments for use in care
settings written in English were eligible for inclusion. The methodological quality of the studies was
assessed using the COSMIN checklist. Feasibility was assessed using a checklist developed speciﬁcally for
the review.
Results: Six hundred and sixteen articles were identiﬁed in the initial search. After de-duplication, screening
and further lateral searches were performed, 25 studies reporting on 9 dementia-speciﬁc QoL instruments for
use in care home settings were included in the review. Limited evidence was available on the psychometric
properties of many instruments identiﬁed. Higher-quality instruments were not easily accessible or had low
feasibility of use.
Conclusions: Few high-quality instruments of QoL validated for use in care home settings are readily or freely
available. This review highlights the need to develop a well-validatedmeasure of QoL for use within care homes
that is also feasible and accessible.
Key words: dementia, quality of life, care settings, feasibility, psychometrics
Introduction
There are approximately 16,000 care homes in the
UK providing care for an estimated 416,000 people
(Care Quality Commission, 2017a; NIHR, 2016); in
the US over 2 million individuals are cared for in
approximately 45,000 facilities (Centre for Disease
Control and Prevention, 2017). These numbers are
expected to increase with an ageing population
(Prince et al., 2014). It is estimated that anywhere
between 40% and 86% of people living in care homes
have a dementia, either diagnosed or undiagnosed,
or some form of memory impairment ( Jagger and
Lindesay, 1997; Livingston et al., 2017). The large
numbers of people living in care homes has led to a
need to understand the outcomes and experiences of
care by residents in order to make improvements to
care. The quality of care provided in care homes and
its consistency has been questioned, with calls to in-
crease the services provided to vulnerable adults (Care
Quality Commission, 2017b; Department of Health,
Prime Minister’s Ofﬁce, 2015). It has been argued
that one way we may be able to better understand
the outcomes of care in order to improve it is through
the measurement and understanding of quality of life
(QoL) (Black, 2013; Edelman et al., 2005).
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Due to a growing recognition of the importance of
the outcomes of care as well as the process of care
(Sloane et al., 2005), there has been a growing empha-
sis on measuring QoL as a means of understanding
and improving care in care settings. An increasing
amount of research in care homes is being carried out
with QoL as an important outcome for evaluating
interventions (Aspden et al., 2014). A number of
dementia-speciﬁc QoL measures have been devel-
oped; however, most of these were developed and
evaluated in community-dwelling populations, rather
than in care homes (Bowling et al., 2015).
Previous reviews have examined dementia-speciﬁc
QoL instruments in general (Bowling et al., 2015;
Ready and Ott, 2003), and generic QoL measures
available for use in care homes (Aspden et al., 2014).
However, generic QoL measures have limitations in
capturing the experiences of people with dementia
(Smith et al., 2005). No previous review has focused
on the usability of the instruments (e.g. availability,
cost, training, and how easy is it to score and inter-
pret) in care homes settings. Ultimately, the usability
of the instrument is likely to dictate whether an
instrument is used or not. We therefore aimed to
add to previous reviews by carrying out a systematic
review to identify and examine not only the psycho-
metric properties but also the usability of disease-
speciﬁc instruments that measure the QoL of people
living in care homes.
Methods
The protocol for this review is registered in the
International Prospective Register of Systematic
Reviews (PROSPERO) – CRD42017046272.
Inclusion criteria
Studies were included in the review if they met the
following criteria: 1) They described the develop-
ment and/or evaluation of an instrument, or
described the adaptation and evaluation of an exist-
ing instrument for a care home population; 2) the
instrument was a dementia-speciﬁcQoL instrument,
and studies evaluating only generic health-related
QoL instruments in a care home population were
excluded; 3) the study population included residents
living in a care home (including nursing homes), and
data on this group were presented separately from
any others studied; and 4) studies were published in
English. There were no exclusion criteria based on
diagnosis, or non-diagnosis, of dementia.
Search strategy
Articles were identiﬁed from initial searches in four
electronic databases: PubMed, PsycINFO, Web of
Science, and the Cumulative Index to Nursing and
Allied Health Literature (CINAHL). All searches
were conducted in January 2017. There were no
restrictions on date of publication. The following
four combined search terms were used: 1) quality
of life OR QOL OR health related quality of life OR
HRQOL OR HRQL, AND 2) dementia OR Alz-
heimer’s, AND 3) residential facilities OR residen-
tial OR care institutions OR long-term care OR
nursing homes OR care homes OR residential care
homes, AND 4) measure development OR valid*
OR reliab* OR accuracy OR feasibility OR scale.
Lateral searches involved checking the references of
included studies (snowballing), and further search-
ing for identiﬁed measures on PubMed and Google
search engine. Two independent reviewers (LH &
NF) screened article titles and abstracts against the
predeﬁned inclusion criteria. Full text articles were
sought for all relevant studies. Any disagreements
regarding inclusion were resolved through discus-
sion by the two reviewers.
Data extraction
Two reviewers (LH&TEP) independently extracted
the following data from included full-texts: name
of instrument, country, language of instrument,
sample characteristics (i.e., age, gender, and demen-
tia severity), study design, measurement domains,
individual items, number of items, response format,
and evidence of reliability and validity.
The reviewers also extracted the following data
about the usability of each instrument through
reading the identiﬁed articles, internet searches
(Google.com, ﬁrst 30 hits) and a measure speciﬁc
database (Mapi; https://mapi-trust.org/). Data
included:
• Existence of a dedicated website (Yes/No) – The
accessibility of an online website or repository, which
contains dedicated information about the instrument
• User guide available (Yes/No) – The availability of
a user guide or instructions about how to use the
instrument
• Cost (paid, free, or other) – The cost of using the
questionnaire, broken down by user type when
provided
• Training – Details about what training is available
for the instrument, whether it is a prerequisite, and
the costs involved
• Time to complete measure (minutes)
• Time period the instrument captures
• Need for specialist software for scoring and inter-
pretation (Yes/No)
• Guidance available for scoring and interpretation
(Yes/No)
“Not known” was used in instances where we were
unable to identify measure speciﬁc information.
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Quality assessment
The methodological quality of the studies was
assessed using the Consensus-based Standards for
the selection of health Measurement Instruments
(COSMIN) checklist (Mokkink et al., 2010). This
is a standardized tool which assesses the measure-
ment properties of health-related instruments across
nine domains (internal consistency, reliability, mea-
surement error, content validity [including face
validity], construct validity [subdivided into struc-
tural validity, hypotheses testing, and cross-cultural
validity], criterion validity and responsiveness) with
each domain rated using 5–18 items. Each item is
rated as “excellent”, “good”, “fair”, or “poor”
quality. A methodological quality score for each
measurement property is obtained by taking the
lowest rating of any item in that box (“worst score
counts”). Two independent reviewers (LH & TEP)
assessed the methodological quality of the included
studies using the checklist. Studies will not be
excluded based on COSMIN scores. Any disagree-
ments in scoring were resolved through discussion
and advice from a third reviewer (NF).
Data synthesis
A narrative synthesis was adopted to assess the
feasibility of theQoLmeasures for use in care homes.
No formal frameworks or criteria exist for the assess-
ment of the feasibility of using QoL measures in care
homes. Therefore, a set of criteria identiﬁed by the
researchers in consultation with care home staff as
important for using QoLmeasures in this setting was
created a priori, based upon the working structure
and practices of care and nursing homes in the UK.
Results
Search results
Initial database searches identiﬁed 616 articles, of
which 269 were removed after duplicate deletion.
The titles and abstracts of 347 articles were screened
resulting in the exclusion of 308 articles. Full text
papers of the remaining 38 articles were sought.
After reviewing full texts, 19 articles met the inclu-
sion criteria. Figure 1 illustrates the process. Six
additional articles were identiﬁed from lateral
searches.
In total we included 25 studies in the systematic
review; these reported on nine different QoL instru-
ments for use in care settings. The measures were:
the Dementia Quality of Life (DQoL) (Brod et al.,
1999) (n= 4), Quality of Life in Alzheimer’s Disease
(QOL-AD) (Logsdon et al., 1999) (n= 1), Quality
of Life in Alzheimer’s Disease nursing home version
(QOL-AD NH) (adapted by Edelman and Fulton,
unpublished work) (n= 6), QUALIDEM (Ettema
et al., 2007b) (n= 7), Quality of Life in Late-Stage
Dementia (QUALID) (n= 6) (Weiner et al., 1999),
DementiaCareMapping (DCM) (BradfordDemen-
tia Group, 2005) (n= 5), Alzheimer Disease Related
Quality of Life (ADRQL) (Rabins et al., 1999)
(n= 3), ADRQL revised (Kasper et al., 2009)
(n= 1), and the Quality of Life in Dementia
(QOL-D) (Albert et al., 1996) (n= 1).
Study and measure characteristics
The sample size of the studies ranged from 20 (Beer
et al., 2009) to 973 (Bouman et al., 2011). Table 1
outlines the characteristics of included studies. The
studies recruited participants from theUnited King-
dom (n= 8), the United States (n= 2) Netherlands
(n= 3), Spain (n= 4), Germany (n= 5), Sweden
(n= 1), and Norway (n= 2).
Of the nine instruments identiﬁed, three instru-
ments contained self-report and a proxy report
questions (QOL-AD, QOL-AD NH, and QOL-D),
one instrument contained a self-report questions
only (DQoL), four instruments contained a proxy
report questions only (QUALIDEM, QUALID,
ADRQL, and ADRQL revised), and one instru-
ment consists of a proxy observation tool (DCM).
The number of measurement domains ranged from
1 (QOL-AD, QOL-AD NH, and QUALID) to 9
(QUALIDEM 37 item version). Five instruments
have a Likert scale response format (DQoL, QOL-
AD, QOL-AD NH, QUALID, and DCM), two
have a frequency scale format (e.g., never, some-
times, often) (QUALIDEM and QOL-D), and
two instruments have a dichotomous response for-
mat (e.g., agree/disagree) (ADRQL and ADRQL
revised). The number of items in each instrument
ranged from 6 (affect subscale of QOL-D) to 40
(ADRQL revised). See Supplementary Table 1 for
full details.
Six instruments were developed speciﬁcally for
use in care settings (QUALID,QUALIDEM,DCM,
ADRQL, ADRQL revised, and QoL-D), and one
was adapted for use in care settings and evaluated
(QOL-AD NH). The QOL-AD and DQoL were
evaluated for use in care settings but were not devel-
oped or adapted for this purpose.
Psychometric properties
The instrument with the most comprehensive eval-
uation of psychometric properties across the nine
domains of the COSMIN checklist was the QUA-
LID with seven domains assessed in two separate
studies. The DQoL, QOL-AD, QUALIDEM, and
DCMhad four domains assessed in at least one study.
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The instruments with the least domains assessed were
QOL-AD NH (n= 3), QOL-D (n= 3), ADRQL
(n= 3), and ADRQL revised (n= 1). See Table 2
for results of the COSMIN checklist.
Internal consistency
All nine instruments had internal consistency re-
ported in at least one study. Instruments that were
reported on the most were QUALID (six studies
with poor to good ratings), and QUALIDEM (ﬁve
studies, poor to excellent quality ratings). Most of
the instruments had acceptable to good internal
consistency across some studies. QOL-AD,ADRQL
Revised, and QOL-AD NH all had the highest
internal consistency scores in a single or small num-
ber of studies (all >0.80). QUALID had the most
consistent high internal consistency scores for mul-
tiple studies (all >0.70). All other instruments had
variability in scores from poor to excellent internal
consistency.
Reliability
Test retest and inter-rater reliability were rated in
eight instruments (n= 15). The most assessed in-
struments wereQUALIDEM,QUALID, andDCM
(n= 4). QUALIDEM was rated fair to good, QUA-
LID and DCM were both rated poor to fair. QOL-
AD NH was assessed in three studies (poor to fair),
DQoL was assessed in two (fair), and the QOL-AD
(poor) ADRQL (fair), and QOL-D (fair) were as-
sessed in one study. Time between tests for test-
retest reliability ranged from 2–3 days (QUALID) to
12 months (DQoL). There was large variability in
reliability scores for instruments. QOL-D and
ADRQL both had the highest reliability, from a
single study each (>0.95). QUALID had the highest
Figure 1. Flow diagram of study selelction.
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Table 1. Characteristics of included studies
POPULATION CHARACTERISTICS (RESIDENTS)
INSTRUMENT USED COUNTRY N GENDER (% F) MEAN AGE (SD)
COGNITIVE IMPAIRMENT
MEAN (SD)/N (%)
...........................................................................................................................................................................................................................................................................................................................................................................................................................................................................
Adler and Resnick (2010) DQOL United Kingdom 486 80 83.8 (8.2) MMSE 20.4 (5.3)
Beer et al. (2009) QOL-AD NH United Kingdom 20 70 87.5 (8.1) MMSE 15.4 (5.2)
Bouman et al. (2011) QUALIDEM Netherlands 973 71–76 across four
samples
83.9 (5.8) GDS <7, N = 759
GDS 7, N = 214
Clare et al. (2014a) QUALID United Kingdom 105 69 81.47 (8.63) FAST 6, N = 25 (24%)
FAST 7, N = 80 (76%)
Crespo et al. (2011) QOL-AD NH Spain 209 79.4 86.07 (6.46) MMSE 13.3 (5.88)
Dichter et al. (2011) QUALIDEM Germany 486 74 mild-moderate
79 severe-very severe
– MMSE <24 = 15.4 (4)
MMSE <10 = 3 (3)
Dichter et al. (2013) QUALIDEM Germany 634 78.6 mild-severe
77.7 very severe
85.8 (8.0) mild-severe
84.5 (8.2) very severe
FAST 2–6, N = 378 (100%)
FAST 7, N = 256 (100%)
Dichter et al. (2014) QUALIDEM Germany 161 91 mild-severe
75 very severe
85.2 (7.0) mild-severe
84.3 (9.0) very severe
FAST 2–6, N = 108 (100%)
FAST 7, N = 53 (100%)
Dichter et al. (2016a) QUALIDEM Germany 91 78 mild-severe
92 very severe
84.7 (8.3) mild-severe
84.1 (9.4) very severe
FAST 2–6, N = 55 (100%)
Dichter et al. (2016b) QOL-AD NH Germany 29 66 88.2 (7.1) Not reported
Edelman et al. (2005) QOL-AD NH
DQoL
ADRQL
DCM
United Kingdom 172 83.7 85.8 (6.4) MMSE 9.0 (6.9)
Ettema et al. (2007a) QUALIDEM Netherlands 202 – – GDS <7, N = 202 (100%)
Ettema et al. (2007b) QUALIDEM Netherlands* 238 76.5 84.69 (6.85) GDS 2–6, N = 202 (100%)
GDS 7, N = 36 (100%)
Falk et al. (2007) QUALID Sweden 169 88 86 (6.0) MMSE 10 (7)
Fossey et al. (2002) DCM United Kingdom 123 (A)
54 (B)
76 cohort A
35 cohort B
82.3 (7.4) cohort A
78.2 (9.1) cohort B
Cohort A, MMSE 9.5 (7.7).
CDR stages 1 = 19%,
2 = 38%, 3 = 43%
Cohort B, 100% CDR stage 3
Garre-Olmo et al. (2010) QUALID Spain 160 76.9 82.6 (11.6) MMSE = 4.1 (6.3)
Kasper et al. (2009) ADRQL
ADRQL revised
United States 89 – – (–) –
León-Salas et al. (2011) QOL-AD Spain 101 88.1 83.2 (6.3) MMSE = 7.2 (6.1)
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Table 1. Continued
POPULATION CHARACTERISTICS (RESIDENTS)
INSTRUMENT USED COUNTRY N GENDER (% F) MEAN AGE (SD)
COGNITIVE IMPAIRMENT
MEAN (SD)/N (%)
...........................................................................................................................................................................................................................................................................................................................................................................................................................................................................
Mjorud et al. (2014) QUALID Norway 661 71.4 85.3 (8.6) CDR stages 1:
N = 147, 2:
N = 222, 3: N = 290
Moyle et al. (2012) DQoL
QOL-AD NH
United Kingdom 61 70.5 MMSE 20–30 = 38 (62.3%)
10–19 = 22 (36.1%)
0–9 = 1 (1.6%)
Røen et al. (2015) QUALID Norway 169 56.6 reliability study
69.2 validity study
83.2 (7.5) reliability study
84.9 (6.7) validity study
MMSE 13.6 (6.1) reliability
study
MMSE 14.0 (6.0)
validity study
Sloane et al. (2005) QOL-D
QOL-AD NH
ADRQL
DQoL
DCM
United Kingdom 421 79 85 (–) MMSE
Mild <17 = 12%
Moderate 10–16 = 25%
Severe 3–9 = 27%
Very severe <2 = 37%
Sloane et al. (2007) DCM United Kingdom – – – –
Villar et al. (2015) DCM Spain 68 66.7 86.08 (7.04) MMSE = 18.09 (3.75
Weiner et al. (1999) QUALID United States 42 67 80.6 (–) MMSE = 11.53 (6.23)
*English language instrument used.
ADRQL, AlzheimerDisease RelatedQuality of Life; ADRQL revised, AlzheimerDisease RelatedQuality of Life revised version; DCM,Dementia CareMapping; DQoL,Dementia quality of life; QOL-
AD, Quality of Life in Alzheimer’s Disease; QOL-ADNH, Quality of Life in Alzheimer’s Disease nursing home version; QOL-D, Quality of Life in Dementia; QUALID, The quality of life in late-stage
dementia; QUALIDEM,Quality of life instrument for proxy completion;MMSE,MiniMental State Examination (Folstein et al., 1975); FAST, Functional Assessment Staging (Reisberg, 1988); GDS,
Global Deterioration Scale (Reisberg et al., 1982); CDR, Clinical Dementia Rating Scale (Morris, 1997); –=Not reported.
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Table 2. Results of consensus-based standards for the selection of health measurement instruments (COSMIN) checklist
QOL
INSTRUMENT AUTHOR(S)
INTERNAL
CONSISTENCY RELIABILITY
MEASUREMENT
ERROR
CONTENT
VALIDITY
STRUCTURAL
VALIDITY
HYPOTHESIS
TESTING
CROSS-
CULTURAL
VALIDITY
CRITERION
VALIDITY RESPONSIVENESS
...........................................................................................................................................................................................................................................................................................................................................................................................................................................................................
DQoL Edelman et al.
(2005)
Good • • • Poor Poor • • •
Adler and
Resnick
(2010)
Poor Fair • • Fair • • Poor •
Moyle et al.
(2012)
Poor • • • • Fair • • •
Sloane et al.
(2005)
Poor Fair • • • Poor • • •
QOL-AD NH Edelman et al.
(2005)
Good • • • Poor Poor • • •
Moyle et al.
(2012)
Poor • • • • Fair • • •
Sloane et al.
(2005)
Poor Fair • • • Poor • • •
Crespo et al.
(2011)
Poor Fair • • • • Poor • •
Dichter et al.
(2016b)
• • • • • • Fair • •
Beer et al.
(2009)
• Poor • • • • • • •
QUALIDEM Dichter et al.
(2013)
Excellent • • • Excellent • • • •
Bouman et al.
(2011)
Excellent Fair • • Excellent • • • •
Dichter et al.
(2011)
Good • • • Fair • Poor • •
Ettema et al.
(2007b)
Poor Good • Fair Good • • • •
Dichter et al.
(2016a)
Poor Fair • • • • • • •
Dichter et al.
(2014)
• Fair • • • • • • •
Ettema et al.
(2007a)
• • • • • Fair • • •
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Table 2. Continued
QOL
INSTRUMENT AUTHOR(S)
INTERNAL
CONSISTENCY RELIABILITY
MEASUREMENT
ERROR
CONTENT
VALIDITY
STRUCTURAL
VALIDITY
HYPOTHESIS
TESTING
CROSS-
CULTURAL
VALIDITY
CRITERION
VALIDITY RESPONSIVENESS
...........................................................................................................................................................................................................................................................................................................................................................................................................................................................................
QUALID Garre-Olmo
et al. (2010)
Good Fair Fair • Fair Fair Poor Poor •
Mjorud et al.
(2014)
Good • • • Excellent • • • •
Clare et al.
(2014a)
Fair • • • Fair • • • •
Falk et al.
(2007)
Fair Poor • • Fair Poor Poor Poor Poor
Røen et al.
(2015)
Poor Fair • • • Poor Poor • •
Weiner et al.
(1999)
Poor Poor • • Poor Fair • • •
ADRQL Edelman et al.
(2005)
Poor • • • Poor Poor • • •
Sloane et al.
(2005)
Poor Fair • • • Poor • • •
Kasper et al.
(2009)
• • • • • • • • •
ADRQL revised Kasper et al.
(2009)
Poor • • • • • • • •
DCM Villar et al.
(2015)
Good Poor • • Fair Fair • • •
Fossey et al.
(2002)
Poor Fair • • Poor Poor • • •
Sloane et al.
(2007)
• Fair • • • • • • •
Sloane et al.
(2005)
• Fair • • • Poor • • •
Edelman et al.
(2005)
• • • • • Poor • • •
QOL-AD León-Salas
et al. (2011)
Poor Poor Fair • • Fair • • •
QOL-D Sloane et al.
(2005)
Poor Fair • • • Poor • • •
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reliability scores from a larger number of studies
(0.69–0.95).
Measurement error
QUALID and QOL-AD were the only instruments
to have measurement error assessed; both were
given fair quality ratings.
Content validity
Content validity was assessed in QUALIDEM only,
and was rated as fair quality. Structural validity was
assessed in six instruments; the instruments most
assessed were QUALID, rated in ﬁve studies with
poor to excellent ratings, andQUALIDEM, rated in
four studies with fair to excellent ratings. DQoL and
DCM were rated in two studies with fair to poor
ratings for both. QOL-AD NH and ADRQL were
assessed once with poor ratings.
Hypothesis testing
Hypothesis testing was carried out for eight instru-
ments. The most assessed instruments were QUA-
LID and DCM, which were assessed in four studies
with poor to fair ratings. DQoL and QOL-AD NH
were assessed in three studies with poor to fair
ratings each. ADRQL was assessed in two studies
with poor ratings, QUALIDEM and QOL-AD were
assessed once with fair ratings, QOL-D had one
poor rating.
Cross-cultural validity
Cross-cultural validity was assessed for three instru-
ments (QUALID,QOL-ADNH, andQUALIDEM).
QUALID and QOL-AD NH were both assessed
twice. QUALID had poor ratings, QOL-AD NH
had a poor and a fair rating. QUALIDEM was as-
sessed once and had a poor rating.
Criterion validity
Criterion validity was assessed for two instruments.
QUALIDwas assessed twice, both with poor ratings,
and DQoL was assessed once with a poor rating.
Only the QUALID was assessed for responsiveness
and this had a poor rating.
Feasibility properties
Feasibility properties were extracted for all instru-
ments, except for the case of the QoL-D, in which
the original questionnaire and associated materials
could not be identiﬁed even after contacting the
original author. Full details of availability and feasi-
bility properties are presented in Table 3.
Dedicated website
Four of the instruments (QOL-AD, QUALIDEM,
ADRQL revised, and DQoL) had dedicated web-
sites where they could be accessed. The ADRQL
revised and QOL-AD were both available via the
online MAPI trust repository. All other instru-
ments required contacting the original author to
access.
User guide
A user guide was accessible for six of the instruments
(QOL-AD, QOL-AD NH, QUALIDEM, DCM,
ADEQL, ADRQL revised), withmany also including
additional instructions on the actual questionnaire.
We were unable to identify any user instructions for
the DQoL and QUALID.
Cost
All instruments were free to access for non-funded
research. Additional charges applied for funded
research and commercial users in the case of the
ADRQL, ADQRL revised, QOL-AD andQOL-AD
NH. A single instrument (DCM)was free to use, but
required users to attend training, which had associ-
ated costs.
Training
Four instruments (DQoL, QOL-AD, QOL-AD
NH, and QUALIDEM) did not require any formal
training before use of the instrument, whilst the
ADRQL and ADRQL revised recommended users
to watch a free training video. Only the DCM
instrument required users to attend a three-day
training course. It was unclear whether the QUA-
LID required training.
Time to complete
Time to complete the instrument ranged from 5
minutes (QUALIDEM, QOL-AD NH) to up to 6
hours (DCM).
Time period to assess
Three instruments captured “present” QoL (QOL-
AD, QOL-AD NH, DCM), whilst the remaining
instruments assessed QoL over the previous 1 or 2
weeks. The only exception is the DQoL which does
not state the time period in which participants
should be assessed.
Specialist software
No instrument appeared to require the use of spe-
cialist software for the administration, analysis, or
interpretation of the instruments.
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Table 3. Availability and feasibility properties of identified instruments
AVAILABILITY USABILITY
SCALE
DEDICATED
WEBSITE USER GUIDE COST
TRAINING
REQUIRED
TIME TO
COMPLETE
TIME PERIOD
TO ASSESS
SPECIALIST
SOFTWARE
REQUIRED?
SCORING
GUIDE
.............................................................................................................................................................................................................................................................................................................................................................................................................................................................................
DQoL No No Free None 10 minutes Not stated Not stated Scoring
instructions in
original paper
(Brod et al. 1999)
QOL-AD No* Yes, and instructions
on instrument
Free to non-funded
academic
researchersa
None 5 mins proxy10–15
mins self-report
Present time
(e.g. within the
past few weeks)
No Yes
QOL-AD NH No Yes, and instructions
on instrument
Free to non-funded
academic
researchersa
None 5 mins proxy10–15
mins self-report
Present time
(e.g. within the
past few weeks)
No Yes
QUALIDEM No Yes Free None 10 minutes 2 weeks Dutch
version, 1 week
English and
German versions
No Yes, on instrument
and in user guide
QUALID No No Free Not known 5 minutes 1 week No Yes, scoring
instructions on
instrument
DCM Yes Yes Free after training Required 3 day
training (£975)
Up to six hours
observation
Present time Not required
but available
Yes
ADRQL Yes Yes, and instructions
on instrument
Free to non-funded
academic
researchersb
Recommended
use of ADRQL
training video
(free)
10–15 mins 2 weeks No Yes
ADRQL
Revised
Yes* Yes, and instructions
on instrument
Free to non-funded
academic
researchersb
Recommended
use of the
ADRQL training
video (free)
10–15 mins 2 weeks No Yes
QoL-D No Not known Not known Not known Not known Not known Not known Not known
All information correct as of January 2018.
*Not a dedicated website but available from MAPI trust repository.
aNon-funded academic researchers - free; Funded academic researchers - €300 per study and €50 per language; Commercial users – Royalty fees €1000 per study and €50 per language. Distribution fees
€1000 per study and €50 per language.
bNon-funded academic researchers — free; Funded academic researchers — €300 per study and €50 per language; Commercial users – Royalty fees 10,000 USD per study and 500 USD per language.
Distribution fees €700 per study and €300 per language.
10
L.
J.
H
ughes
et
al.
https://w
w
w
.cam
bridge.org/core/term
s. https://doi.org/10.1017/S1041610218002259
D
ow
nloaded from
 https://w
w
w
.cam
bridge.org/core. U
niversity of Sussex Library, on 03 Jan 2019 at 13:08:58, subject to the C
am
bridge C
ore term
s of use, available at
Scoring guide
All instruments had accessible scoring instructions.
Discussion
This study aimed to add usefully to existing reviews
of the literature (Bowling et al., 2015; Ready and
Ott, 2003). Aspden et al. (2014) by assessing the
usability properties of instruments in care homes in
addition to psychometric properties and study qual-
ity. This provides broader information on the prag-
matic use of dementia-speciﬁc QoL instruments in
care homes, which is likely to be of value to research-
ers, clinicians, and practitioners when selecting in-
struments for use both in research and in normal
practice.
Twenty-ﬁve studies were identiﬁed that assessed
nine dementia speciﬁc QoL instruments for use in
care homes. This review highlights that even though
QoL instruments exist for use in care homes, they
may not be accessible or feasible for use. There was
limited information about the psychometric proper-
ties of most instruments; as a consequence many
elements were not assessed. COSMIN scores that
were assessed had relatively low ratings with the
majority of ratings being poor or fair. The instru-
ments with the most psychometric evidence were
QUALID and QUALIDEM. The QUALID instru-
ment had the most extensive evaluation of the two,
with seven domains assessed, however, QUALI-
DEM had better ratings for most of the assessed
properties with more excellent and good ratings
compared to QUALID. The QUALIDEM has pre-
viously been suggested as the best QoL instrument
to use for people with dementia in care homes due to
the comprehensive assessment of its measurement
properties (Aspden et al., 2014).
The QOL-AD instrument is one of the most
widely used QoL instruments due to its good psy-
chometric properties and apparent ease of use
(Bowling et al., 2015). However, ﬁndings from the
review show limited use of the QOL-AD in care
settings, with the original QOL-AD only identiﬁed
in one study, and the nursing home version identi-
ﬁed in six studies. The QOL-AD NH instrument,
which is adapted from QOL-AD was assessed in six
studies; however, the ratings were mainly poor or
fair. These ﬁndings are in line with a previous review
which found that the QOL-AD NH properties were
poor because of small sample sizes and methodo-
logical quality of the studies (Aspden et al., 2014).
It is widely accepted that measuring QoL in care
settings is important. This is usually carried out as a
part of research with the focus being to understand
changes to QoL over time or to assess outcomes of
interventions (Clare et al., 2014b; Hoe et al., 2009).
There is, however, an additional need and potential
beneﬁt in understanding the QoL of care home
residents outside of research, in routine care prac-
tice. The lack of routine measurement of QoL in
care homes will be in part due to differences in
the current instruments and a lack of consensus
about what a QoL instrument should contain.
The frameworks of QoL in dementia underpinning
each instrument inﬂuence and shape the instrument
and its content (Missotten et al., 2016). The instru-
ments discussed here are based on a small number
of models. Most are based solely, or in part, on the
work of Lawton (Missotten et al., 2016), which
states that QoL in dementia is multidimensional
and consists of both objective and subjective com-
ponents. A health-related QoL deﬁnition, which
only includes aspects of QoL affected by a health
condition, and the adaptation-coping model, which
is concerned with adaptation to the consequences
of dementia (Dröes et al., 2010) have also been
used. However, it is often not clear what conceptual
framework instruments are based on, and what as-
sumptions are made (Bowling et al., 2015;Missotten
et al., 2016). This may dissuade some from using
QoL instruments, and the differences in the content
of instruments may inﬂuence whether or not speciﬁc
instruments are used. This, coupled with what it
is that practitioners, researchers, or clinicianswant to
gain frommeasuring QoLwill inﬂuence the decision
about what instrument to use. However a fundamen-
tal problem is likely to be limited access to and
experience of QoL instruments as well as a lack of
requirement by regulators to use such approaches.
Most are difﬁcult to ﬁnd and access online; often
requiring contacting the original author or register-
ing with online instrument repositories to request
access to speciﬁc instruments. This will be difﬁcult
for care staff who may not be aware of the different
instruments available andmay not have the skills and
resources needed to identify them.
Routine use of QoL instrumentsmight be of value
at an individual resident level and also at an aggregate
level providing insights into the QoL of residents as
a whole and indirectly the home as a whole. QoL
measurement has the potential to improve the pro-
vision of person-centered or holistic care by encour-
aging care staff to focus more on the individual and
less on impairments of function (Edvardsson et al.,
2014). The inclusion of an instrument to speciﬁcally
measure QoL in normal care practice, and used in
conjunction with existing care practices, procedures,
and documentation, could enhance the opportunity
to improve care quality by providing more person-
centered information on residents and providing
feedback on the effect of changes over time. In the
US, a comprehensive assessment of a variety of care
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features is completed for residents in long-term care
facilities. The Resident Assessment Instrument
(RAI-NH) is completed periodically to collect and
record relevant information about resident care. The
aim of its use is to inform holistic care and ensure
good QoL and quality of care. Implementation and
use of the RAI-NH has been shown to be associated
with improvements in resident outcomes (Fries et al.,
1997; Phillips et al., 1997). The integration of a QoL
instrument into such a system and used regularly
could enhance the assessment of resident outcomes
by providing complementary information and there-
fore a broader understanding of wellbeing of the
resident and when aggregated further insights into
the quality of the care home. In the UK and many
other countries there is no suchmandated combined
assessment schedule in the care sector and no culture
of routine measurement; resident and care factors
are documented by staff, in a less systematic manner
than in the RAI-NH. Therefore, integrating QoL
measurement into routine care practicewould need a
different approach. Regardless of the systems that
currently exist in homes, such action would require
appropriate instruments that are accessible for and
usable by care home staff. Of all the instruments that
were available, the QOL-AD, QUALIDEM, and
ADRQL revised were accessible via simple internet
searches and had a dedicated web page. Importantly,
many of the measures were difﬁcult to access, and
required contacting the original author (e.g., DQoL).
Overall, the QUALIDEM was assessed as the most
accessible; being free to use, with all information
regarding administration and scoring available in
an extensive user guide. However, although an
English language version ofQUALIDEM is available,
it has not been validated in an English sample as far as
could be determined from this review. Therefore,
despite QUALIDEM being the most psychometri-
cally robust and accessible instrument there is still
some concern regarding whether it is suitable for use
in an English-speaking sample and setting.
In this review we focus on dementia-speciﬁc QoL
instruments. A previous review by Aspden and
colleagues suggested that one instrument should
be used for people with dementia and another for
people without dementia (Aspden et al., 2014). We
understand the clarity of purpose behind this, but
believe that in routine care practice, when those
with dementia are in the majority, it may be prefera-
ble to use a single dementia-speciﬁc instrument for
three main reasons. First, using two different instru-
mentsmakes it difﬁcult to aggregate scores for homes
overall, and changes to resident status (from no
diagnosis to diagnosis) would require a change in
instrument, thus meaning a lack of consistent
measurement for that individual resident over time.
Second, dual measurement is dependent on an
accurate diagnosis of a dementia having been
made for each resident and this is unlikely to be the
case. Diagnosis rates in the UK are amongst the
highest in the world but are still only around 67%
(Department of Health, 2016). Many without a
formal diagnosis of dementia in care homes will in
fact have dementia, and evidence of high prevalence
of dementia in care homes mean that most residents
would be appropriate for the use of a dementia-
speciﬁcQoL instrument (Jagger and Lindesay, 1997;
Livingston et al., 2017). Finally, the questions con-
tained inQoL instruments need to be appropriate for
people with dementia and for use in care settings.
Few generic measures of QoL have been developed
speciﬁcally for use in care home settings, and very
few have been validated in this setting. They can,
therefore, contain inappropriate questions, often
reﬂecting the opportunity to perform a function
rather than the ability to perform it (Hall et al., 2011).
We believe that the content of dementia-speciﬁcQoL
instruments may be a better ﬁt for care home resi-
dents, even those without dementia, than generic
instruments. This can be posed as an empirical
question and requires research to be done to test
this hypothesis. On balance we believe a strategy of
dual measurement may introduce more measure-
ment error than it prevents with the addition of
unnecessary complexity.
Despite differences in the content of instruments
and the ﬁndings presented in this review, the use of
existing QoL instruments is preferable to using no
QoL instruments at all. They provide potentially
valuable information compared with not using
them. There is, however, a need for the development
of instruments that are developed and/or validated
to measure QoL in care home settings and that
are accessible, easy to use, and contain appropriate
questions. The future development and adaptation
of instruments needs to consider these care-home
speciﬁc points to create instruments that are of
demonstrable beneﬁt and lead to the wider use of
QoL instruments in care homes.
In this review we do not recommend the use of
one instrument as being the best or most appropriate
to use. Instead, because there is no gold standard
instrument, we argue that there are factors other
than psychometric properties that should be consid-
ered when deciding on an appropriate instrument to
use in care settings, particularly if the care staff will
be involved in collecting data. We conclude that
new instruments need to be developed either from
existing measures or de novo that are speciﬁc to the
care home setting, that have acceptable psychomet-
ric properties and that are readily accessible and
usable in these settings. Deciding on what instru-
ment is the most useful in care settings is difﬁcult
given the differences in care homes themselves.
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Issues of time and resources and the beneﬁt that
accrues from their use will always be to the fore, so
data on these parameters are needed. The develop-
ment or adaptation of instruments that can be used
in care homes by both researchers and by care staff
routinely in normal care practice would be useful. If
adapted, the content of such instruments would
need to remain largely the same to maintain reliabil-
ity and validity of the instrument. However, the
format or layout of the instrument questions, and
user guides or instructions would need to be adapted
for use in care homes and by care staff. Researchers
will be speciﬁcally trained and experienced in using
standardised instruments and are likely to havemore
time to complete instruments. Care staff are likely
to need more speciﬁc guidelines to follow and a
layout that reduces the risk of recording error and
missing data.
It is important to highlight several limitations of
this review. First, this review did not include all
measures of dementia-speciﬁc QoL, because they
did not meet inclusion criteria of this review. For
example, the Philadelphia Geriatric Centre Affect
Rating Scale (PGC-ARS) (Lawton et al., 1996)
and the Resident and Staff Observation Checklist
Quality of Lifemeasure (RSOC-QOL) (Sloane et al.,
1991) were not included in this review despite being
included in a review by Aspden and colleagues as the
instruments were not assessed to be measures of
QoL (Aspden et al., 2014). Second, there is no
established means of assessing the usability of in-
struments in care homes, and therefore interpreta-
tion of what is considered “accessible” or “practical”
may differ depending on the user. Third, this review
focused on disease-speciﬁc instruments of QoL and
makes the assumption that the majority of residents
in a care home would have dementia; this may not be
the case and could affect the validity of instruments.
Finally, this review only included articles published
in English, meaning that non-English instruments
may not have been captured.
Conclusion
The number of high quality easily accessible instru-
ments available for use in care homes is low. In
general, the psychometric analysis of instruments
revealed them to function poorly in care home
settings with a limited number of psychometric
elements assessed for each instrument in any single
study. Furthermore, the quality ratings of each
instrument were weak with very few receiving excel-
lent or good ratings. Instruments with the best
psychometric assessments were not necessarily eas-
ily accessible, and those that were readily available
had some of the poorest quality and most limited
assessment. The ﬁndings of this review indicate that
there is a need for further large and well-designed
evaluations of the properties of these instruments
when used in care homes, including head-to-head
comparisons. Further work is also needed in order
to ensure that any instruments are made easily
available for use by care staff if they are to be
used in a non-research or clinical capacity. Due to
poor psychometric and feasibility properties, none
of the instruments currently available seem suited to
routine use by care staff in care homes. Further
development of existing instruments or the genera-
tion of newmethods for the measurement of QoL in
care homes would be of potential value given the
need to assure and improve the quality of care of
residents in care homes with dementia.
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